Clicky

Moderna Inc.(0A45)

Description: Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


Keywords:

Home Page: www.modernatx.com

0A45 Technical Analysis

200 Technology Square
Cambridge, MA 02139
United States
Phone: 617 714 6500


Officers

Name Title
Mr. Stephane Bancel CEO & Director
Dr. Stephen Hoge M.D. President
Mr. James M. Mock Chief Financial Officer
Ms. Shannon Thyme Klinger J.D. Chief Legal Officer & Corporate Secretary
Dr. Jerh Collins Ph.D. Chief Technical Operations & Quality Officer
Ms. Lavina Talukdar CFA Senior VP & Head of Investor Relations
Colleen Hussey Senior Director of Corporate Communications
Ms. Tracey Franklin Chief People & Digital Technology Officer
Dr. Melanie Ivarsson M.B.A., Ph.D. Chief Development Officer
Mr. Dave Johnson Chief Data & AI Officer

Exchange: LSE

Country: GB : United Kingdom of Great Britain and Northern Ireland

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0.0491
Price-to-Book MRQ: 0
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: December
Full Time Employees: 5600
Back to stocks